EA201900244A1 - Антибактериальные средства на основе производных ципрофлоксацина - Google Patents
Антибактериальные средства на основе производных ципрофлоксацинаInfo
- Publication number
- EA201900244A1 EA201900244A1 EA201900244A EA201900244A EA201900244A1 EA 201900244 A1 EA201900244 A1 EA 201900244A1 EA 201900244 A EA201900244 A EA 201900244A EA 201900244 A EA201900244 A EA 201900244A EA 201900244 A1 EA201900244 A1 EA 201900244A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- antibacterial agents
- agents based
- ciprofloxacin
- ciprofloxacin derivatives
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Изобретение относится к химии органических гетероциклических соединений, а именно к новым производным ципрофлоксацина общей формулы (I), проявляющим антибактериальные свойства.Изобретение может найти применение в медицине и ветеринарии.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2016143072A RU2636751C1 (ru) | 2016-11-02 | 2016-11-02 | Антибактериальные средства на основе производных ципрофлоксацина |
PCT/RU2017/000807 WO2018084747A1 (ru) | 2016-11-02 | 2017-10-31 | Антибактериальные средства на основе производных ципрофлоксацина |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201900244A1 true EA201900244A1 (ru) | 2019-08-30 |
EA034063B1 EA034063B1 (ru) | 2019-12-24 |
Family
ID=60581583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201900244A EA034063B1 (ru) | 2016-11-02 | 2017-10-31 | Антибактериальные средства на основе производных ципрофлоксацина |
Country Status (7)
Country | Link |
---|---|
US (1) | US10759810B2 (ru) |
EP (1) | EP3517527B1 (ru) |
JP (1) | JP6793927B2 (ru) |
CN (1) | CN110088090A (ru) |
EA (1) | EA034063B1 (ru) |
RU (1) | RU2636751C1 (ru) |
WO (1) | WO2018084747A1 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2713932C1 (ru) * | 2019-10-31 | 2020-02-11 | федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) | Соединения фторхинолонового ряда на основе производных пиридоксина, обладающие антибактериальными свойствами |
CN112480099A (zh) * | 2020-12-22 | 2021-03-12 | 广东省微生物研究所(广东省微生物分析检测中心) | 1,3,4-恶二唑-环丙沙星杂合体及其制备方法和应用 |
RU2757741C1 (ru) * | 2021-03-01 | 2021-10-21 | Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) | Производное ципрофлоксацина, обладающее антибактериальной активностью в отношении антибиотикоустойчивых штаммов микроорганизмов |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4620007A (en) * | 1980-09-03 | 1986-10-28 | Bayer Aktiengesellschaft | 6-fluoro-7-chloro-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid |
US20020025964A1 (en) * | 1986-01-21 | 2002-02-28 | Bernd Streuff | Pharmaceutical formulations of ciprofloxacin |
MY138335A (en) * | 1997-09-15 | 2009-05-29 | Procter & Gamble | Antimicrobial quinolones, their compositions and uses |
AU757805B2 (en) * | 1998-11-24 | 2003-03-06 | Daiichi Pharmaceutical Co., Ltd. | Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
US6777420B2 (en) * | 2001-06-15 | 2004-08-17 | Microbiotix, Inc. | Heterocyclic antibacterial compounds |
WO2003031441A1 (en) * | 2001-10-04 | 2003-04-17 | Morphochen Aktiengesellschaft Für Kombinatorische Chemie | Multiple action compounds |
WO2011034971A1 (en) | 2009-09-15 | 2011-03-24 | Designmedix, Inc. | Modified fluoroquinolone compounds and methods of using the same |
RU2466728C1 (ru) | 2011-09-12 | 2012-11-20 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) | Фосфониевые соли на основе производных пиридоксина |
EP2957561A1 (en) * | 2014-06-18 | 2015-12-23 | Université Paris 6 Pierre et Marie Curie UPMC | Novel fluoroquinolones and use thereof to treat bacterial infections |
-
2016
- 2016-11-02 RU RU2016143072A patent/RU2636751C1/ru active
-
2017
- 2017-10-31 WO PCT/RU2017/000807 patent/WO2018084747A1/ru active Search and Examination
- 2017-10-31 JP JP2019545235A patent/JP6793927B2/ja active Active
- 2017-10-31 EP EP17868394.2A patent/EP3517527B1/en active Active
- 2017-10-31 EA EA201900244A patent/EA034063B1/ru unknown
- 2017-10-31 CN CN201780067642.5A patent/CN110088090A/zh active Pending
-
2019
- 2019-04-29 US US16/397,860 patent/US10759810B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20190248802A1 (en) | 2019-08-15 |
US10759810B2 (en) | 2020-09-01 |
EA034063B1 (ru) | 2019-12-24 |
EP3517527B1 (en) | 2020-04-15 |
RU2636751C1 (ru) | 2017-12-01 |
EP3517527A4 (en) | 2019-08-28 |
JP6793927B2 (ja) | 2020-12-02 |
CN110088090A (zh) | 2019-08-02 |
EP3517527A1 (en) | 2019-07-31 |
WO2018084747A1 (ru) | 2018-05-11 |
JP2020508999A (ja) | 2020-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018007528A2 (es) | Compuestos heterocíclicos como inmunomoduladores | |
CO2019000386A2 (es) | Compuestos heterocíclicos como inmunomoduladores | |
EA201990044A1 (ru) | Гетероциклические соединения в качестве антибактериальных средств | |
CY1121938T1 (el) | Αγωνιστες apj 4-υδροξυ-3-(ετερο¶ρυλ)πυριδινο-2-ονης για χρηση στη θεραπεια καρδιαγγειακων διαταραχων | |
NI201900070A (es) | Compuestos heterocíclicos como inmunomoduladores | |
EA201790271A1 (ru) | Ингибиторы гликозидазы | |
EA201792205A1 (ru) | Гетероциклические соединения как ингибиторы lsd1 | |
EA201891203A1 (ru) | Гетероциклические соединения в качестве иммуномодуляторов | |
EA201692316A1 (ru) | Производные холана для применения при лечении и/или профилактике fxr и tgr5/gpbar1-опосредованных заболеваний | |
EA201990615A1 (ru) | Пирролобензодиазепиновые конъюгаты | |
EA201790649A1 (ru) | Бензилзамещенные индазолы в качестве ингибиторов bub 1 | |
EA201892123A1 (ru) | 6-гидрокси-4-оксо-1,4-дигидропиримидин-5-карбоксамиды в качестве агонистов apj | |
EA201890858A1 (ru) | 2,4-дигидроксиникотинамиды как агонисты apj | |
EA201691272A1 (ru) | Тетрагидропиридопиразины в качестве модуляторов gpr6 | |
EA201591728A1 (ru) | Гетероциклические соединения и способы их применения | |
EA201890592A1 (ru) | Жидкие фармацевтические композиции, содержащие ингибиторы sglt-2 | |
CY1123221T1 (el) | Ενωσεις θειαζολιδιου για αντιμετωπιση ιογενων λοιμοξεων | |
EA201692358A1 (ru) | Производные изоиндолина для применения в лечении вирусной инфекции | |
EA201990159A1 (ru) | Биарилметильные гетероциклы | |
EA201790206A1 (ru) | Новые 2,5-замещенные пиримидины в качестве ингибиторов pde4 | |
EA201790207A1 (ru) | Новые замещенные пиримидиновые соединения | |
EA201790939A1 (ru) | ТРИАЗОЛО[4,5-d]ПИРИМИДИНЫ В КАЧЕСТВЕ АГОНИСТОВ КАННАБИНОИДНЫХ РЕЦЕПТОРОВ ТИПА 2 | |
EA201792287A1 (ru) | Способы лечения рака | |
EA201691983A1 (ru) | Пиридин-2-амиды, пригодные в качестве агонистов cb2 | |
EA201791530A1 (ru) | НОВЫЕ N-АЦИЛАРИЛСУЛЬФОНАМИДНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ АМИНОАЦИЛ-тРНК СИНТЕТАЗЫ |